Gruzinova I, Daines MO. Alternaria alternata serine proteases induce lung inflammation and airway epithelial cell activation via PAR2.
response to A. alternata filtrates was dependent on PAR2 expression in stably transfected HeLa cell models. These data demonstrate that A. alternata proteases act through PAR 2 to induce rapid increases in human airway epithelial [Ca 2ϩ ]i in vitro and cell recruitment in vivo. These responses are likely critical early steps in the development of allergic asthma. allergic asthma; Alternaria; inflammation; calcium; innate immunity ALTERNARIA ALTERNATA SENSITIZATION is an important factor in the onset of childhood allergic asthma in semiarid regions (7, 11, 14, 17, 33) . A. alternata is a complex allergen with many potentially sensitizing proteins that can directly impact epithelial cell biology. Epithelial cells provide innate immune defense against airborne environmental constituents. Many of the particulates encountered in the air we breathe are captured and removed by the mucociliary escalator. Others are engulfed by the phagocytic cells of the lung and metabolized. Certain ubiquitous environmental constituents lead to the production of a variety of cytokines and growth factors and thus contribute to airway innate immunity. These constituents include a variety of proteases from several biological sources related to allergic asthma and include microbes, insects, and arthropods (16, 18, 35) .
Allergens associated with asthma (asthmagens) contain microbe-associated molecular patterns such as lipopolysaccharide, peptidglycan, or double-stranded DNA molecules that act on a variety of pattern recognition receptors (e.g., Toll-like receptors, Dectins, or Nod-like receptors). A second set of recognition receptors in the airway is the protease-activated receptors (PARs). The PAR family of G protein-coupled receptors (GPCR) consists of four members (PAR 1 , PAR 2 , PAR 3 , and PAR 4 ) that are activated by exogenous or endogenous proteases (30, 37) . Protease cleavage of the NH 2 -terminus of these receptors exposes a tethered ligand that interacts with the receptors to initiate GPCR signaling pathways. PAR 2 is expressed in a variety of tissues, including the airway epithelium (38) . The contribution of PAR activation to airway physiology has been the subject of many reviews (16, 18, 20, 35) . However, specific roles for PAR activation in airway physiology and pathophysiology remain ill-defined.
PARs can be activated in vivo following exposure to endogenous (e.g., thrombin, tryptase, clotting factors) or exogenous (e.g., from housedust mite, A. alternata, cockroach) proteases. PAR 2 is unique from the other three PARs in that it is not activated by thrombin (22, 30, 34) . A significant tool for the study of PARs is the use of small peptides or peptidomimetics that mimic the natural, protease-cleaved tethered ligand (26, 29, 34) . These peptides provide a key advantage in studying PAR responses and subsequent cellular signaling because they directly target individual receptors without the nonspecific action of proteases. At high concentrations, peptides and peptidomimetics also can be used to desensitize cells by effectively inactivating the PAR response (23) .
In this report, we provide evidence that serine-specific proteases derived from A. alternata induce an asthma-associated physiological response in vivo, immune cell recruitment to the lung. We further characterize A. alternata protease contribution to cellular signaling in human airway epithelial cells as activating PAR 2 . Understanding and controlling the role(s) of allergen-associated proteases and their effect on PAR 2 will allow for insight into allergic lung diseases such as asthma.
MATERIALS AND METHODS

Materials.
Eagles minimum essential medium with Earle's salts (MEM), F-12K medium, Lechner and LaVeck basal medium, Hanks' balanced saline solution (HBSS), L-glutamine, penicillin, streptomycin, geneticin, Trizol reagent, Platinum SYBR Green qPCR SuperMix-UDG kit, Quant-iT, and the OliGreen quantification kit were purchased from InVitrogen (Carlsbad, CA). Fibronectin and type I collagen were purchased from Becton-Dickinson (Franklin Lakes, NJ). The iScript cDNA Synthesis kit was from Bio-Rad (Hercules, CA). Primers for real-time RT-PCR experiments were from Integrated DNA Technologies (Coralville, IA). A. alternata inocula to establish filtrates for in vitro experiments were from the American Type Culture Collection (ATCC, Manassas, VA). A. alternata filtrate used in vivo was from Greer laboratories (Lenoir, NC). Protease inhibitor cocktail (used at a final concentration of: 1.0 mM AEBSF, 0.8 M aprotinin, 21 M leupeptin, 36 M bestatin, 15 M pepstatin A, and 14 M E-64) was from Sigma-Aldrich (St. Louis, MO). All other chemicals were of the highest biochemical quality and purchased from Sigma-Aldrich, VWR (West Chester, PA), or Fisher Scientific (Pittsburgh, PA).
A. alternata filtrate. For in vitro experiments, A. alternata spore suspensions (ATCC catalog no. 11680) were initially grown at 25°C on potato-dextrose agar. At day 7, 10 ml of 0.001% Tween 20 were added to the plate, and the conidia were gently dislodged using a bent glass rod. One milliliter of the resulting spore suspension (ϳ10 6 spores/ml) was used to inoculate 100 ml HBSS (1.3 mM CaCl2, 5.0 mM KCl, 0.3 mM KH 2PO4, 0.5 mM MgCl2, 0.4 mM MgSO4, 137.9 mM NaCl, 0.3 mM Na 2PO4, and 1% glucose additionally buffered with 25 mM HEPES, pH 7.4) amended with 0.12% DL-asparagine and incubated in shake culture (120 rpm) at 25°C. At day 7, fungal tissue was separated by filtering through sterile Miracloth. Filtrate was collected, standardized for protein and protease content, and then frozen for future experiments. Filtrate used in in vitro experiments contained 650 g/ml protein as determined with the Pierce bicinchoninic acid protein assay per the manufacturer's instructions (ThermoFisher Scientific, Waltham, MA). Protease activity was comparable to 0.1 g/ml trypsin using the manufacturer's protocol supplied with the Sigma protease assay kit (catalog no. PF-0100: specific activity of trypsin not available from the supplier). If one assumes that the specific activity of the trypsin supplied in the kit were near maximal (e.g., ϳ20,000 BAEE U/mg), then the A. alternata activity would be equivalent to approximately two BAEE trypsin-like units per milliliter. For comparing different A. alternata preparations, the manufacturer's protocol was employed. All of the A. alternata protease activity was blocked by heat inactivation (30 min, 70°C) or by the serine protease inhibitor AEBSF (0.28 mM). Protease activity was not significantly altered by the cysteine protease inhibitor E-64 (10 M) or the aspartyl protease inhibitor pepstatin (10 M), as measured with this kit. Filtrate used in vivo was obtained via Greer Laboratories and dissolved in HBSS (1 mg/10 ml) with similar protease activity to that grown in culture.
Measurement of in vivo lung cell recruitment. All animal procedures were approved by the Institutional Animal Care and Use Committee of The University of Arizona. We administered 10 g of A. alternata filtrate (in 100 l HBSS) intranasally to 6-wk-old male Balb/c mice under brief isoflurane anesthesia. Anesthesia allowed droplets administered intranasally to be aspirated in the lungs while maintaining spontaneous respiration. A. alternata filtrates were administered three times over an 8-day period. Mice were euthanized on the 9th day by CO2 inhalation 24 h after the last administration of A. alternata filtrate, blood was collected, and lungs were lavaged two times with HBSS by cannulation of the trachea. The collected bronchoalveolar lavage fluid (BALF) was assessed for total cell counts. Cells were cytospun to slides and stained by Diffquick. Cell differentials were determined by manual counting.
16HBE14o-cell culture. 16HBE14o-cells are a SV40 transformed human bronchial epithelial cell line (12) and were obtained through the California Pacific Medical Center Research Institute (San Francisco, CA). 16HBE14o-cells were expanded in tissue culture flasks before culture on 15-mm glass cover slips. Flasks (2 ml) and cover slips (250 l) were coated initially with matrix coating solution [consisting of: 88% LHC basal medium, 10% BSA (from 1 mg/ml stock), 1% bovine collagen type I (from 2.9 mg/ml stock), and 1% human fibronectin (from 1 mg/ml stock solution)] and incubated for 2 h at 37°C, after which the coating solution was removed and cultureware allowed to dry for at least 1 h. 16HBE14o-cells were plated on the matrix-coated cultureware at a concentration of 1 ϫ 10 5 cells/cm 2 . Cells were cultured in ϳ300 l of control growth medium (CGM: Eagle's MEM supplemented with 10% FBS, 2 mM glutamax, penicillin, and streptomycin) at 37°C in a 5% CO 2 atmosphere. CGM was replaced every other day until the cells reached confluence (5-7 days Real-time RT-PCR. 16HBE14o-, HeLa, and PAR2 transfected HeLa cells were grown to confluence in T75 flasks as described above. RNA was isolated using TRIzol reagent (Invitrogen) according to the manufacturer's protocol and quantified using the NanoDrop ND-1000 (Thermo Fisher Scientific). cDNA was synthesized on an iCycler thermocycler (Bio-Rad) using the iScript cDNA synthesis kit according to the manufacturer's protocol and quantified using the Quant-iT OliGreen quantification kit according to the manufacturer's instructions on a TBS-380 minifluorimeter (Turner BioSystems, Sunnyvale, CA). For real-time RT-PCR, 100 ng of total cDNA/ reaction were amplified with a Platinum SYBR Green qPCR SuperMix-UDG kit in a Rotor-Gene 3000 real-time thermal cycler (Corbett Robotics, San Francisco, CA) under the following conditions: initial hold for 2 min at 50°C; hold for 2 min at 95°C; 45 cycles consisting of denature for 15 s at 94°C; anneal 30 s at 58°C; extension for 45 s at 72°C; and melted from 74 to 99°C (1°C/5 s). Primer pairs used to detect PARs and the housekeeping gene GAPDH are listed in Table 1 . Individual analyses were performed in triplicate on cDNA samples.
Statistics. All statistical analyses were evaluated with GraphPad software (San Diego, CA). Multivariate comparisons were done with ANOVA with Bonferroni's multiple-comparison posttest. Pairwise comparisons were done with a two-tailed Student's t-test. A value of P Ͻ 0.05 was used to establish a significant difference between samples. Data in Figs. 1-8 are graphed Ϯ SE unless otherwise noted.
RESULTS
A. alternata protease activity induces immune cell recruitment in murine airways.
To determine if the asthmagen A. alternata had an inflammatory effect on the airway, we developed an in vivo murine model of exposure to A. alternata filtrates. Mice were exposed to 10 g A. alternata filtrates or control buffer (HBSS) at days 1, 4, and 8 and euthanized on day 9 (Fig. 1A) . A. alternata-exposed mice had an average of 2.2 ϫ 10 6 cells recovered from BALF (n ϭ 5), a 16-fold increase over mice administered buffer (HBSS) control (n ϭ 5; Fig. 1B ). To rule out inert contents of the filtrate (e.g., chitin), the filtrates were heated to 70°C for 30 min. Administration of heat-inactivated filtrate resulted in a significant reduction of cell recruitment (2.5 ϫ 10 5 ; n ϭ 5) compared with the untreated filtrate. To more closely evaluate the role for serine proteases in cell recruitment, the experiment was repeated using A. alternata filtrate pretreated with the serine protease specific inhibitor AEBSF (0.1 mM). Under these conditions, cell recruitment was again significantly reduced, with only 5.4 ϫ 10 5 cells recovered from the BALF (n ϭ 5). Mean cellular differential counts showed a statistically significant increase in lymphocytes, neutrophils, macrophages, and eosinophils in mice exposed to A. alternata filtrate proteases compared with mice exposed to HBSS control. There was also a significant increase in all immune cell counts in mice exposed to A. alternata compared with those exposed to heat-inactivated or serine protease-inhibited filtrates. These data show that serinespecific protease activity of A. alternata is required to develop lung inflammation as detected by cell recruitment to the airway.
A 
, E-H).
Replacement of the heat-inactivated filtrate with untreated filtrate resulted in a full Ca 2ϩ response (n ϭ 3; Fig. 2 , I-L). Because heat can alter many components of A. alternata, we specifically evaluated the contribution of proteases by repeating these experiments following A. alternata protease inactivation. A. alternata filtrate was first preincubated with a broadspectrum protease inhibitor cocktail for 5 min and applied to ] i responses in only 2.2 Ϯ 2.1% (n ϭ 5) of 16HBE14o-cells (Fig. 3,  A-D) . To further evaluate the type of proteases that were activating the 16HBE14o-cells, we preincubated A. alternata filtrate with protease inhibitors that reduced A. alternata protease activity (see MATERIALS AND METHODS). We first used the serine protease inhibitor AEBSF (0. Fig. 4 (29) and the potent peptidomimetic 2-furoyl-LIGRLO-NH 2 (21, 26) . The SLI-GRL-NH 2 peptide induced Ca 2ϩ signaling in 88.2 Ϯ 7.1% over a 3-min experiment (n ϭ 3; Fig. 5, A-D) . The 2-furoyl-LIGRLO-NH 2 peptidomimetic was similarly effective (93.6 Ϯ 8.7%; n ϭ 7) but at a much lower concentration (2.5 M; Fig. 5, E-H ). These data demonstrate that direct activation of PAR 2 can lead to robust Ca 2ϩ signaling.
To experimentally evaluate potential contributions of PAR 1 , PAR 3 , or PAR 4 in 16HBE14o-Ca 2ϩ activation, we used a desensitization protocol (23, 26) and monitored changes in [Ca 2ϩ ] i following addition of thrombin (Fig. 6) 4 . However, when 16HBE14o-cells desensitized with three washes of 100 nM thrombin were followed with 2.5 M 2-furoyl-LIGRLO-NH 2 (n ϭ 5) or A. alternata filtrate (n ϭ 5), they responded with full Ca 2ϩ activation (99.1 Ϯ 0.5 and 94.8 Ϯ 1.7%, respectively; Fig. 6 ). To confirm the prominent role for PAR 2 in protease activation of 16HBE14o-cells, we used real-time RT-PCR to evaluate the relative mRNA expression of PAR 1 , PAR 3 , and PAR 4 compared with PAR 2 in 16HBE14o-cells. Of the four PARs, PAR 2 displayed the highest level of expression with PAR 1 also showing significant, albeit much reduced, expression. PAR 3 and PAR 4 displayed limited expression (data not shown). These data are consistent with a PAR 2 dominant protease response to A. alternata filtrates.
We used a second desensitization protocol (23, 26) to further evaluate if functional PAR 2 was required for A. alternatainduced Ca 2ϩ changes (Fig. 7) . First, 16HBE14o-cells were ] i and a second addition of trypsin, Ͻ1% of the cells displayed a Ca 2ϩ response. When cells were exposed to A. alternata following a desensitization, there was no increase in [Ca 2ϩ ] i (n ϭ 4). However, the addition of ATP, which acts on purinergic receptors (2), caused a rapid increase in [Ca 2ϩ ] i in 76.9 Ϯ 15.6% of cells, indicating that cells were still attached and capable of responding to GPCR ligands (Fig.  7, A and C) . The ATP response was comparable to 16HBE14o-cells exposed to A. alternata filtrate without trypsin pretreatment (data not shown). To more directly examine the role of PAR 2 in A. alternata-induced Ca 2ϩ signaling, we repeated the desensitization protocol using a high concentration (100 M) of 2-furoyl-LIGRLO-NH 2 (n ϭ 4; Fig. 7, B and D) (Fig. 8C) . To determine the effect of PAR 2 expression on A. alternata activation, we repeated the [Ca 2ϩ ] i response experiments with A. alternata filtrate (Fig. 8D) . Only 2.0 Ϯ 1.4% (n ϭ 5) of the nontransfected HeLa cells were activated by A. alternata filtrate. In the HeLa transfectant with the low PAR 2 mRNA expression (clone 8), a significant increase in response to A. alternata filtrate was observed (17.3 Ϯ 6.8%; n ϭ 3). A medium expression clone (clone 7) again displayed a significant increase in response (30.3 Ϯ 10.9%; n ϭ 3), whereas the high-expression HeLa transfectant (clone 4B) displayed the highest response (55.6 Ϯ 9.9%; n ϭ 6). Importantly, response to A. alternata filtrate was dependent on the amount of PAR 2 expressed in each clone, further emphasizing the role for PAR 2 in A. alternata filtrate activation.
DISCUSSION
Asthma is a chronic respiratory disease with significant cost, morbidity, and mortality. A critical factor in the development of allergic asthma is environmental allergen exposure and sensitization (3, 28, 35) . Characteristics of allergic asthma include airway inflammation, mucin production, and airway remodeling, all of which may be affected by the interaction between the epithelium and environmental allergens. In this manuscript, we show that filtrates from an asthma-associated allergen (asthmagen), A. alternata, causes airway inflammation in mice, with lung cell recruitment that is dependent on filtrate protease activity. Using a human airway epithelial cell model, we show that serine-specific proteases from A. alternata filtrate directly activate human bronchial epithelial cells via the PAR 2 . Furthermore, filtrate-mediated Ca 2ϩ signaling in epithelial cells requires an active receptor and is dependent on the amount of PAR 2 expressed. Although this is the first report to demonstrate serine-proteases from A. alternata are sufficient to induce airway inflammation in nonsensitized animals, it is in agreement with a recent report demonstrating a role for PAR 2 in German cockroach frass-induced inflammation (32) and with several reports of an asthmagen-PAR 2 axis in inflammation in sensitized mouse models (9, 10, 36) . These results highlight airway epithelial PAR 2 as a site of action for the environmental asthmagens in the development of human allergic asthma.
Allergens as a group have very diverse characteristics, yet only a subset of allergens strongly associate with the development of asthma. A critical element separating asthmagens, including those from cockroach, house dust mite, A. alternata, and Penicillium citrinum, from more benign allergens, is their association with robust protease activity. The proteolytic nature of these allergic pathogens can have direct effects on cells and tissues in the airway. Proteolytic targets include disruption of epithelial cell junctions, depletion of elastase inhibitors, cell receptor cleavage, alteration of salt and water movement, and inactivation of surfactant proteins (15, 38) . These proteases can also have indirect effects, including providing foreign particulates access to underlying cells and tissues in the airway, or activating cellular signaling pathways via PARs (15, 22, 34, 35) . Because activation of PARs can result in inflammatory, growth factor, or other signaling molecule release, they can contribute to some of the downstream physiological changes associated with allergic asthma, including immune cell recruitment, airway remodeling, or bronchoconstriction/bronchodilation. As such, protease interaction with the airway epithelium provides a first recognition of and response to allergen exposure and, thus, a potential site for asthmagens to alter the local physiology and contribute to asthma.
A primary finding of our study is that A. alternata sensitization of the airway is protease-dependent and can directly induce inflammatory cell recruitment to the lung in the absence of sensitizing agents such as alum or ovalbumin. Similar findings have recently been reported from German cockroachderived asthmagens that initiated PAR 2 protease-dependent inflammation independent of sensitization (32) . Because application of these proteases are intranasal and delivered under anesthesia to allow aspiration into the airway, we hypothesized that interaction with airway epithelial cells was likely the site of action of asthmagen proteases. The release of cytokines, chemokines, and other signaling molecules is a potential physiological outcome of PAR 2 activation that could be crucial in our murine model of A. alternata exposure. Consistent with this hypothesis, inflammatory cytokine release (TNF-␣, IL-5, and IL-13) has been measured in animal models following tracheal instillation of PAR 2 activating peptide SLIGRL-NH 2 in ovalbumin-sensitized mice (9, 10) .
Because the epithelium provides the first tissue of contact between asthmagen protease activity and the host cell, we more closely evaluated a human bronchial cell model (16HBE14o-cells) for protease-dependent A. alternata effects. Activation of PARs by exogenous or endogenous proteases occurs through the cleavage of the NH 2 -terminus of the GPCR, which exposes a peptide sequence that can act as a receptor ligand (30, 34, 37) . These tethered ligands then initiate several downstream signaling pathways. In the case of PAR 2 , the primary signaling pathways include Ca 2ϩ , which occurs rapidly after activation, and mitogen-activated protein kinases (MAPK), which can occur over a more prolonged time course. Our report focuses on filtrates from A. alternata exposed to a human bronchial cell line that retains functional tight junctions in culture (39) and thus represents an airway cell model that best allows for apical exposure of the filtrate, as would occur in vivo. It should be noted that previous reports on PAR expression in 16HBE14o-cells have provided evidence for all four PARs being expressed (1, 8) . However, under the growth conditions presented in this manuscript, there is minimal expression of PAR 1 , PAR 3 , and PAR 4 and a corresponding minimal response to thrombin (Fig.  6) , a known activator of all PARs except PAR 2 . Thus 16HBE14o-cells provide an excellent airway cell model for examination of PAR 2 activation. We detail PAR 2 as a target for A. alternata proteases by monitoring rapid changes in [Ca 2ϩ ] i . A. alternata also causes increases in MAPK, as measured by increased phosphorylated ERK 1/2 (data not shown). A variety of endogenous proteases have been associated with PAR 2 activation as well as defined and undefined allergen-associated proteases (35, 37, 38) . Our results are consistent with serine protease(s) derived from A. alternata contributing to PAR 2 activation in human airway epithelial cells.
Airway epithelial cell models have been used in several previous reports to demonstrate inflammatory mediator release following PAR 2 activation by asthmagens, including A. alternata. Protease-dependent activation of an alveolar-derived human lung cell line, A549, by extracts from four fungi, including A. alternata, caused release of the proinflammatory cytokines IL-6 and IL-8 (19) . Similar studies with A549 cells activated by Pen c 13, a protease derived from P. citrinum, (4) or with the PAR 2 -activating peptide SLIGKV-NH 2 (31) demonstrate IL-8 release. However, in both of these reports, it was also shown that PAR 1 could be important in IL-8 release. PAR 2 was involved in thymic stromal lymphopoietin (TSLP) release from a human bronchial epithelial cell line, BEAS-2B, following very high doses of A. alternata (50 -100 g/ml) extract (24) . TSLP release was reduced by PAR 2 knockdown by transfection with small-interfering RNA targeted to PAR 2 , consistent with a PAR 2 -dependent release of TSLP. Although both serine and cysteine proteases could induce TSLP secretion from BEAS-2B cells, the A. alternata response was not blocked by a serine protease inhibitor, APMSF, but was partially blocked by a cysteine protease inhibitor, E-64. A similar response to high concentrations of A. alternata (50 g/ml) generated PAR 2 responses in eosinophils that also were not blocked by serine protease inhibitor APMSF but were blocked by the aspartyl protease inhibitor pepstatin (25) . In our experiments, extracts from A. alternata above 20 g/ml lead to cytotoxicity of 16HBE14o-cells (data not shown), precluding accurate evaluations of these high concentrations of A. alternata. Furthermore, neither the cysteine protease inhibitor E-64 nor the aspartyl protease inhibitor pepstatin altered A. alternata filtrate-induced Ca 2ϩ responses in 16HBE14o-cells used in the present study, suggesting that it is the serine protease activity from A. alternata that leads to airway epithelial activation. The differences observed in previous reports could be due to concentration and/or cytotoxicity effects. However, we cannot rule out differences in response to A. alternata due to cell type, which could include altered PAR 2 allele expression, accessory activating molecules, or G protein signaling, all shown to be important in defining PAR 2 signaling from different cell types (37) . Further work will be needed to better clarify the differences between these model systems and how they impact in vivo response.
In this report, we show that mice exposed to the same A. alternata filtrates that activate PAR 2 in vitro result in proteasedependent inflammatory cell recruitment to the airways. These findings support our hypothesis that airway epithelial PAR 2 responses are involved in host responses to exogenous asthmagens, potentially leading to innate immune activation and inflammation that create symptoms associated with allergic asthma. However, activation of PAR 2 in a variety of animal and activation models has resulted in mixed results as to inflammation in asthma. For example, airway PAR 2 activation can result in proinflammatory effects such as we detail here (5, 9, 10, 32, 36) , but also can result in anti-inflammatory and bronchorelaxant effects (6, 27) . Similar, seemingly contradictory, findings can be found in cellular and tissue models (15) . A full understanding of specific effects of PAR 2 activation will likely include the understanding of signaling pathways triggered under different conditions, coreceptor activation, cell type of activation, presence of antiproteases, as well as genetic backgrounds.
